Skip to main content

RxNews®

Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.

Nemluvio® (nemolizumab-ilto) – New drug approval

August 13, 2024 - Galderma announced the FDA approval of Nemluvio (nemolizumab-ilto), for the treatment of adults with prurigo nodularis.

Download PDF

Rx navigation